Circular RNAs in digestive system cancer: potential biomarkers and therapeutic targets

Jia-Qi Sheng1, Lian Liu1, Mu-Ru Wang1

  • 1Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.

Insights

Circular RNAs (circRNAs) are stable molecules with diverse functions, implicated in various diseases. This review focuses on their diagnostic and therapeutic potential in digestive system cancers.

Area of Science:

  • Molecular Biology
  • Genomics
  • RNA Biology

Background:

  • Circular RNAs (circRNAs) are a class of RNA molecules characterized by a stable, covalently closed loop structure.
  • Advances in high-throughput sequencing have revealed the widespread presence and diverse functions of circRNAs across species and cell types.
  • These functions include regulating gene expression, acting as miRNA sponges, interacting with proteins, and even translating peptides.

Purpose of the Study:

  • To review the latest research on circRNAs.
  • To explore the diagnostic and prognostic significance of circRNAs in digestive system cancers.
  • To highlight the potential of circRNAs as therapeutic targets for novel drugs.

Main Methods:

  • Literature review of recent studies on circRNAs.
  • Analysis of circRNA roles in disease pathogenesis.
  • Focus on circRNAs in the context of digestive system cancers.

Main Results:

  • CircRNAs play critical roles in various biological processes.
  • CircRNAs are involved in the development of numerous diseases, including cancers.
  • Specific circRNAs show promise as diagnostic and prognostic biomarkers for digestive system cancers.

Conclusions:

  • CircRNAs represent a significant area of research with broad biological implications.
  • CircRNAs hold considerable potential as diagnostic and prognostic indicators in digestive system cancers.
  • Targeting circRNAs may offer novel therapeutic strategies for digestive system cancers.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.7K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Carbohydrate Digestion00:57

Carbohydrate Digestion

Carbohydrate digestion and metabolism break down simple and complex carbohydrates from food into saccharides (i.e., sugars) for the body to use as energy. Carbohydrate digestion starts in the mouth during mastication, or chewing. The masticated carbohydrates remain intact in the stomach. Digestion resumes in the duodenum of the small intestine, where pancreatic alpha-amylase and brush border enzymes of the microvilli convert complex carbohydrates to monosaccharides. Finally, the monosaccharides...
122.6K
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
75.4K